{"count": 3, "results": [{"_id": "33270043", "pmid": 33270043, "title": "Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus.", "journal": "Eur J Endocrinol", "authors": ["Tseng CH"], "date": "2021-02-01T00:00:00Z", "doi": "10.1530/EJE-20-0507", "meta_date_publication": "2021 Feb", "meta_volume": "184", "meta_issue": "2", "meta_pages": "299-310", "score": 50260.76, "text_hl": "CONCLUSION: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use is associated with a lower risk of OS/@<m>DISEASE_Spondylocostal_dysostosis_autosomal_recessive</m> @DISEASE_MESH:C535781 @@@VF@@@.", "citations": {"NLM": "Tseng CH. Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus. Eur J Endocrinol. 2021 Feb;184(2):299-310. PMID: 33270043", "BibTeX": "@article{33270043, title={Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus.}, author={Tseng CH}, journal={Eur J Endocrinol}, volume={184}, number={2}, pages={299-310}}"}}, {"_id": "19527806", "pmid": 19527806, "title": "Vertebral fractures in males with type 2 diabetes treated with rosiglitazone.", "journal": "Bone", "authors": ["Mancini T", "Mazziotti G", "Doga M", "Carpinteri R", "Simetovic N", "Vescovi PP", "Giustina A"], "date": "2009-10-01T00:00:00Z", "doi": "10.1016/j.bone.2009.06.006", "meta_date_publication": "2009 Oct", "meta_volume": "45", "meta_issue": "4", "meta_pages": "784-8", "score": 50066.11, "text_hl": "RESULTS: @<m>DISEASE_Spondylocostal_dysostosis_autosomal_recessive</m> @DISEASE_MESH:C535781 @@@Vertebral fractures@@@ were found in 46.5% of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ males (p=0.06 vs. control subjects) with higher prevalence in @SPECIES_9606 @@@patients@@@ treated with @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@ plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as compared with those under treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ alone (66.7% vs. 27.3%; p=0.01). ", "citations": {"NLM": "Mancini T, Mazziotti G, Doga M, Carpinteri R, Simetovic N, Vescovi PP, Giustina A. Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone. 2009 Oct;45(4):784-8. PMID: 19527806", "BibTeX": "@article{19527806, title={Vertebral fractures in males with type 2 diabetes treated with rosiglitazone.}, author={Mancini T and Mazziotti G and Doga M and Carpinteri R and Simetovic N and Vescovi PP and Giustina A}, journal={Bone}, volume={45}, number={4}, pages={784-8}}"}}, {"_id": "27080708", "pmid": 27080708, "title": "Risk of fractures and diabetes medications: a nationwide cohort study.", "journal": "Osteoporos Int", "authors": ["Choi HJ", "Park C", "Lee YK", "Ha YC", "Jang S", "Shin CS"], "date": "2016-09-01T00:00:00Z", "doi": "10.1007/s00198-016-3595-6", "meta_date_publication": "2016 Sep", "meta_volume": "27", "meta_issue": "9", "meta_pages": "2709-2715", "score": 50048.715, "text_hl": "Compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ + @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@SU@@@ users, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ + DPP4-I users showed a trend of lower non-@<m>DISEASE_Spondylocostal_dysostosis_autosomal_recessive</m> @DISEASE_MESH:C535781 @@@vertebral fracture@@@ risk (HR = 0.82, P = 0.086) after adjusting for all confounding variables. ", "citations": {"NLM": "Choi HJ, Park C, Lee YK, Ha YC, Jang S, Shin CS. Risk of fractures and diabetes medications: a nationwide cohort study. Osteoporos Int. 2016 Sep;27(9):2709-2715. PMID: 27080708", "BibTeX": "@article{27080708, title={Risk of fractures and diabetes medications: a nationwide cohort study.}, author={Choi HJ and Park C and Lee YK and Ha YC and Jang S and Shin CS}, journal={Osteoporos Int}, volume={27}, number={9}, pages={2709-2715}}"}}]}